Physician profile
Benjamin Lin
NPI 1801355888
$2,917.44
in general payments reported to CMS, 2019-2025
11 companies · $742 in 2025
The $742 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,461 · 2024: $715 · 2025: $742.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,917.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,917.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,040.85 | 2023-2025 | Constellation, Unity, Ngenuity |
| Alimera Sciences, INC. | $656.10 | 2023 | Iluvien, Yutiq |
| Dutch Ophthalmic, USA | $346.93 | 2023-2025 | Eva, Combined Machine, Tissueblue |
| Bausch & Lomb Americas INC. | $264.19 | 2025 | Stellaris, Stellaris |
| Regeneron Healthcare Solutions, INC. | $170.53 | 2023-2025 | Eylea Hd, Eylea |
| Glaukos Corporation | $165.12 | 2023 | |
| Astellas Pharma US INC | $111.15 | 2023 | |
| Harrow Eye, LLC | $85.35 | 2024-2025 | Iheezo, Triesence |
| Apellis Pharmaceuticals, INC. | $31.46 | 2025 | Syfovre |
| Ani Pharmaceuticals, INC. | $26.43 | 2024 | Purified Cortrophin Gel |
| Genentech USA, INC. | $19.33 | 2025 | Vabysmo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.